安大略省婴儿麻疹易感性缺口调查
本研究在安大略省多伦多病童医院对12月龄以下婴儿及其母亲开展横断面研究,计算婴儿麻疹易感性概率并按年龄预测平均抗体滴度。麻疹血清流行率从出生第一个月的70.4%(38/54)降至四个月龄的0.0%(0/18),校正母亲出生地和麻疹免疫状态后,易感性几率随月龄增加约增至三倍。
要点
- 婴儿麻疹血清流行率从第一个月70.4%(38/54)降至四个月龄0.0%(0/18)。
- 校正母亲出生地和麻疹免疫状态后,易感性几率随月龄增加约增至三倍。
- 所有暴露于麻疹的婴儿无论年龄均应推定为易感。
核心结论
- 研究中的婴儿在出生后第一年的大部分时间可能对麻疹易感。
- 所有暴露于麻疹的婴儿无论年龄均应推定为易感。
- 高人群水平麻疹疫苗覆盖率对保护该易感人群至关重要。
研究设计与样本
- 在安大略省多伦多病童医院开展横断面研究,纳入12月龄以下婴儿及其母亲。
- 计算婴儿麻疹易感性概率并按年龄预测平均抗体滴度。
- 回归模型校正母亲出生地和麻疹免疫状态。
主要发现
- 麻疹血清流行率随年龄下降,出生第一个月为70.4%(38/54),四个月龄降至0.0%(0/18)。
- 校正母亲出生地和麻疹免疫状态后,易感性几率随月龄增加约增至三倍。
临床怎么用
- 作者认为所有暴露于麻疹的婴儿无论年龄均应推定为易感。
- 作者认为高人群水平麻疹疫苗覆盖率对保护该易感人群至关重要。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prior to receiving their first dose of measles-containing vaccine, infants may be protected against infection either via antibodies obtained transplacentally from their mothers or by herd immunity. However, there is evidence that transplacental protection may wane well-before the age of first measles vaccination. METHODS: We conducted a cross-sectional study of infants <12 months of age at The Hospital for Sick Children (SickKids) in Toronto, Ontario, and their mothers. We calculated the probability of measles susceptibility in infants and predicted the mean antibody titre by age. RESULTS: Measles seroprevalence decreased with age, starting at 70.4 % (38/54) in the first month of life and declining to 0.0 % (0/18) by four months of age. Regression models adjusted for maternal place of birth and measles immunity status indicated that the odds of susceptibility approximately tripled with every increasing month of age. INTERPRETATION: Infants in our study are likely susceptible to measles for the majority of their first year of life. All measles-exposed infants should be presumed susceptible, regardless of age. High population-level measles vaccine coverage is essential to protect this susceptible population.
引用
- Bolotin S, Wright J, McLachlan E, et al. Investigating the measles susceptibility gap in Ontario infants. Vaccine. 2025. PMID: 40048933. doi:10.1016/j.vaccine.2025.126908
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。